Dual-targeted and controlled release delivery of doxorubicin to breast adenocarcinoma: In vitro and in vivo studies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dual-targeted and controlled release delivery of doxorubicin to breast adenocarcinoma: In vitro and in vivo studies

Published:2022-07 Issue: Volume:623 Page:121892
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Jamshidi Zahra,Sadat Zavvar Taraneh,Ramezani Mohammad,Alibolandi Mona,Hadizadeh Farzin,Abnous Khalil,Taghdisi Seyed Mohammad

Funder

Mashhad University of Medical Sciences

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference50 articles.

1. Folate receptor-targeted multimodal polymersomes for delivery of quantum dots and doxorubicin to breast adenocarcinoma: in vitro and in vivo evaluation;Alibolandi;Int. J. Pharm.,2016

2. Progress in adjuvant chemotherapy for breast cancer: an overview;Anampa;BMC Med.,2015

3. Doxorubicin: Anticancer Antibiotics;Arcamone,2012

4. Nanoparticles and targeted drug delivery in cancer therapy;Bahrami;Immunol. Lett.,2017

5. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering extracellular vesicles derived from lemons for delivering chemotherapeutic drug employing periostin targeting;Journal of Drug Delivery Science and Technology;2024-09

2. Autophagy manipulation augments programmed cell death-induced immune responses against tumor;Chemical Engineering Journal;2024-09

3. A comprehensive review on doxorubicin: mechanisms, toxicity, clinical trials, combination therapies and nanoformulations in breast cancer;Drug Delivery and Translational Research;2024-06-17

4. Surface modification of hollow gold nanoparticles conducted by incorporating cancer cell membrane and AS1411 aptamer, aiming to achieve a dual-targeted therapy for colorectal cancer;International Journal of Pharmaceutics;2024-04

5. Doxorubicin conjugates: a practical approach for its cardiotoxicity alleviation;Expert Opinion on Drug Delivery;2024-03-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3